Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2026-01-04 @ 7:37 AM
Study NCT ID:
NCT04072250
Status:
COMPLETED
Last Update Posted:
2019-09-13
First Post:
2019-08-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Surgery for Recurrent Intrahepatic Cholangiocarcinoma
Sponsor:
Chang Gung Memorial Hospital
Organization:
Study Overview
Official Title:
Surgery for Recurrent Intrahepatic Cholangiocarcinoma: a Promise or an Excess?
Status:
COMPLETED
Status Verified Date:
2018-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators retrospectively reviewed the participants suffering from recurrent intrahepatic cholangiocarcinoma after curative resection and aimed to explore the predictive factors for recurrence and clarify the potential benefit of repeat hepatectomy or/with metastasectomy.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: